Publications by authors named "Stuart Grossman"

Claim this Profile
V
Volumetric Analysis of Contrast Enhancement in Patients With Newly Diagnosed Glioblastomas.
Max A Saint-Germain, Mohamed Sherief, Haris I Sair, Karisa C Schreck, Debraj Mukherjee, Stuart A Grossman

Neurosurgery· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas.
David Schiff, Xiaobu Ye, Jing Li, Benjamin M Ellingson, Patrick Y Wen, Stuart Grossman

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Fractionated Radiation Therapy as a Chemopotentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase 1/2 Trial.
Timothy Lin, Suqi Ke, Chen Hu, Ryan Assadi, James Huang, Stuart Grossman

Int J Radiat Oncol Biol Phys· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma.
Jian L Campian, Stuart A Grossman, Angela Shaulov Kask, Samuel Kosydar, Roy Strowd

Neurooncol Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a pre-radiation window to identify potentially active cytotoxic agents in adults with newly diagnosed glioblastoma.
Danielle A Bazer, Antonio C Wolff, Stuart A Grossman

Neuro Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma.
Eudocia Q Lee, Brian M Alexander, Carlos G Romo, Jeffrey G Supko, Nathalie Y R Agar, Stuart A Grossman

Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma.
Patrick Y Wen, Andrea Manzanera, Caroline Duault, Edgar Gonzalez-Kozlova, Lenika Lopez, Stuart A Grossman

Neuro Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal metastatic disease: new frontiers and future directions.
Ahmad Ozair, Hannah Wilding, Debarati Bhanja, Nicholas Mikolajewicz, Michael Glantz, Stuart A Grossman

Nat Rev Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.
Veronica Rendo, Eudocia Q Lee, Connor Bossi, Nicholas Khuu, Michelle A Rudek, Stuart A Grossman

Sci Transl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomas.
Stuart A Grossman, Carlos G Romo, Xiaobu Ye, Brian Kral, Roy E Strowd

Neurooncol Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation immunodynamics in patients with glioblastoma receiving chemoradiation.
Lindsey Sloan, Rupashree Sen, Chunnan Liu, Michele Doucet, Lee Blosser, Stuart Grossman

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Stuart A Grossman

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma.
Veronica Rendo, Eudocia Q Lee, Connor Bossi, Nicholas Khuu, Michelle A Rudek, Stuart A Grossman

medRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma.
Matthias Holdhoff, Xiaobu Ye, Roy E Strowd, Burt Nabors, Tobias Walbert, Stuart A Grossman

Neurooncol Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR).
Manmeet S Ahluwalia, Ahmad Ozair, Michelle Rudek, Xiaobu Ye, Matthias Holdhoff, Stuart A Grossman

Cell Rep Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma.
Samuel Ryu, Xiaobu Ye, Jeffrey J Olson, Tom Mikkelsen, Lev Bangiyev, Stuart A Grossman

Neurooncol Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.
Karisa C Schreck, Roy E Strowd, Louis B Nabors, Benjamin M Ellingson, Michael Chang, Stuart A Grossman

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.
John B Fiveash, Xiaobu Ye, David M Peerboom, Tom Mikkelsen, Sajeel Chowdhary, Stuart Grossman

PLoS One· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM).
Lawrence Kleinberg, Xiaobu Ye, Jeff Supko, Glen H J Stevens, Hui-Kuo Shu, Stuart A Grossman

J Neurooncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Druggable genomic landscapes of high-grade gliomas.
Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Stuart A Grossman

Front Med (Lausanne)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas.
Qianqi Huang, Jingpu Wu, Nhat Le, Yiqing Shen, Pengfei Guo, Stuart A Grossman

Magn Reson Imaging· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
Roy Strowd, Benjamin Ellingson, Catalina Raymond, Jingwen Yao, Patrick Y Wen, Stuart Grossman

J Neurooncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-Site Phase I Trial of Veliparib with Standard Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM).
Lawrence Kleinberg, Xiaobu Ye, Jeff Supko, Glenn H J Stevens, Hui-Kuo Shu, Stuart Grossman

Res Sq· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using historical objective response rates to design single-arm phase II trials in patients with recurrent glioblastoma.
Stuart A Grossman

Neuro Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders.
David O Kamson, Viveka Chinnasamy, Stuart A Grossman, Chetan Bettegowda, Peter B Barker

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis